The Prioritization Of Anti Counterfeiting Measures In Developing Countries Heat Map
The Prioritization of Anti-Counterfeiting Measures in Developing Countries [Heat Map]
Developing countries are the worst affected from counterfeit
pharmaceuticals, regulatory structures are weaker and measurement and
oversight is difficult. According to the World Health Organization, an
estimated 1 in 10 medical products in low- and middle-income countries
is substandard or falsified. This heat map specifically focuses in on
the largest counterfeiting markets: Africa, China, and India. Download
this map to learn about the latest advancements developing countries
have taken to combat anti-counterfeiting and which country needs
to start making it a priority.
Please note: That all fields marked with an asterisk (*) are required.
*Processing your payment may take a moment. Please click submit payment only once, and do not refresh this page. Doing so may result in your credit card being charged more than once.